Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. R. Furman
Ofatumumab Monotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Final Results From a Pivotal Study
Haematologica
Hematology
Phase I to III Trials of Anti-B Cell Therapy in Non-Hodgkin's Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
R-Dhap Is Effective in Fludarabine-Refractory Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia
Clinical Cancer Research
Cancer Research
Oncology
Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?
Therapeutic Advances in Hematology
Hematology
Refractory Chronic Lymphocytic Leukemia – New Therapeutic Strategies
Oncotarget
Oncology
Five‐year Survival Follow‐up of a Phase III Randomised Trial Comparing Ofatumumab Versus Physicians' Choice for Bulky Fludarabine‐refractory Chronic Lymphocytic Leukaemia: A Short Report
British Journal of Haematology
Hematology
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
The Role of Ofatumumab in the Treatment of Chronic Lymphocytic Leukemia Resistant to Previous Therapies
Journal of Blood Medicine
Hematology
Real World Outcomes of Obinutuzumab Monotherapy in Patients With Chronic Lymphocytic Leukemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
